The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Nadroparin calcium Aspen Forte 19,000 I.U. anti-Xa/ml solution for injection in a pre-filled syringe

19,000 international unit(s)/millilitre Solution for injection in pre-filled syringe

Aspen Pharma Trading LimitedPA1691/019/003

Main Information

Trade NameNadroparin calcium Aspen Forte 19,000 I.U. anti-Xa/ml solution for injection in a pre-filled syringe
Active SubstancesNadroparin calcium
Strength19,000 international unit(s)/millilitre
Dosage FormSolution for injection in pre-filled syringe
Licence HolderAspen Pharma Trading Limited
Licence NumberPA1691/019/003

Group Information

ATC CodeB01AB Heparin group
B01AB06 nadroparin

Status

Authorised/WithdrawnAuthorised
Licence Issued04/05/2018
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back